GILENYA®
Indications

Gilenya is indicated as monotherapy for the treatment of adult patients and paediatric patients of 10 years of age and above with the relapsing-remitting form of multiple sclerosis to reduce the frequency of clinical exacerbations and to delay the progression of physical disability.

GILENYA®

Package Insert

Rate this content: 
0
No votes yet
FA-11236893, FA-11236897, FA-11236891
×

Medical Information Request

×

Ask Speakers